---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-075194"
form_type: "8-K"
ticker: "ASTH"
cik: "0001083446"
company_name: "Astrana Health, Inc."
filed_at: "2025-08-07T23:59:59+00:00"
generated_at: "2026-05-17T17:04:04.054968+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Astrana Health Q2 revenue $654.8M, +35% YoY; adjusted EBITDA $48.1M, guidance reiterated

## Summary
- Total revenue $654.8M, up 35% from $486.3M; adjusted EBITDA $48.1M, both at higher end of guidance.
- Net income $9.4M, EPS-diluted $0.19; six-month EPS $0.33.
- Care Partners revenue $631.4M, up 36% YoY.
- Reiterates full-year 2025 guidance, inclusive of completed Prospect Health acquisition.
- Medical cost trends within expectations across all lines of business.

## SEC filing metadata
- accession: 0001104659-25-075194
- form_type: 8-K
- ticker: ASTH
- cik: 0001083446
- company_name: Astrana Health, Inc.
- filed_at: 2025-08-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1083446/000110465925075194/0001104659-25-075194-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1083446/000110465925075194/tm2521330d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-075194
- JSON: https://secwatch.observer/filing/0001104659-25-075194.json
- Plain text: https://secwatch.observer/filing/0001104659-25-075194.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.